⌘K

Exicure, Inc. (XCUR)

$3.93 71.62% $1.64 Healthcare

Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

Market cap

$6.80M

CEO

Dr. Matthias G. Schroff Ph.D.

Full time employees

37.00

Headquarters

Chicago, IL

IPO Date

May 09, 2018

Price-to-earnings (PE) Ratio

-0.87

Earnings-per-share (EPS)

$-4.50

Cash ratio (TTM)

1.63

Current ratio (TTM)

2.56

Earnings yield (TTM)

85.41%

Net profit margin (TTM)

13.55%

PE ratio (TTM)

1.17

PEG ratio (TTM)

-0.01

Price-to-book ratio (TTM)

0.43

Price-to-sales ratio (TTM)

0.16

Quick ratio (TTM)

1.63

Return on assets (TTM)

20.27%

Return on equity (TTM)

40.04%

Similar stocks (15)

Eliem Therapeutics, Inc.

ELYM

$8.28 3.76% $0.30

Uptrend

scPharmaceuticals Inc.

SCPH

$5.26 -3.13% $-0.17

Neutral

DiaMedica Therapeutics Inc.

DMAC

$4.04 -2.18% $-0.09

Uptrend

Seres Therapeutics, Inc.

MCRB

$1.05 0.00% $0.00

Uptrend

Ikena Oncology, Inc.

IKNA

$1.71 3.01% $0.05

Neutral

PMV Pharmaceuticals, Inc.

PMVP

$1.52 0.66% $0.01

Downtrend

Tempest Therapeutics, Inc.

TPST

$1.41 0.00% $0.00

Downtrend

Lumos Pharma, Inc.

LUMO

$3.92 5.95% $0.22

Neutral

Marker Therapeutics, Inc.

MRKR

$2.93 5.78% $0.16

Downtrend

RenovoRx, Inc.

RNXT

$0.98 -0.61% $-0.00

Downtrend

HCW Biologics Inc.

HCWB

$0.50 -16.65% $-0.10

Downtrend

Imunon, Inc.

IMNN

$1.07 -6.14% $-0.07

Neutral

Protagenic Therapeutics, Inc.

PTIX

$0.59 -5.26% $-0.03

Downtrend

Cyclacel Pharmaceuticals, Inc.

CYCC

$1.02 -2.39% $-0.02

Downtrend

Histogen Inc.

HSTO

$0.22 0.00% $0.00

Downtrend

ETF Exposure (2)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$138.77 2.02% $2.75

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend

Downtrend

Similar stocks (15)

Eliem Therapeutics, Inc.

ELYM

$8.28 3.76% $0.30

Uptrend

scPharmaceuticals Inc.

SCPH

$5.26 -3.13% $-0.17

Neutral

DiaMedica Therapeutics Inc.

DMAC

$4.04 -2.18% $-0.09

Uptrend

Seres Therapeutics, Inc.

MCRB

$1.05 0.00% $0.00

Uptrend

Ikena Oncology, Inc.

IKNA

$1.71 3.01% $0.05

Neutral

PMV Pharmaceuticals, Inc.

PMVP

$1.52 0.66% $0.01

Downtrend

Tempest Therapeutics, Inc.

TPST

$1.41 0.00% $0.00

Downtrend

Lumos Pharma, Inc.

LUMO

$3.92 5.95% $0.22

Neutral

Marker Therapeutics, Inc.

MRKR

$2.93 5.78% $0.16

Downtrend

RenovoRx, Inc.

RNXT

$0.98 -0.61% $-0.00

Downtrend

HCW Biologics Inc.

HCWB

$0.50 -16.65% $-0.10

Downtrend

Imunon, Inc.

IMNN

$1.07 -6.14% $-0.07

Neutral

Protagenic Therapeutics, Inc.

PTIX

$0.59 -5.26% $-0.03

Downtrend

Cyclacel Pharmaceuticals, Inc.

CYCC

$1.02 -2.39% $-0.02

Downtrend

Histogen Inc.

HSTO

$0.22 0.00% $0.00

Downtrend

ETF Exposure (2)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$138.77 2.02% $2.75

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend